Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
Clinical trial NCT02284893 · COMPLETED
Trial details
- NCT number
- NCT02284893
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-09
- Primary completion
- 2016-09-20
- Enrollment
- 461
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.